International biotechnology companies seeking to conduct clinical trials in Australia will be excited to learn of the NSW Government’s capability to fast track clinical trials. Learn how NSW can create a competitive advantage for your business by facilitating fast, high quality and cost-effective clinical trials.
Already, Sydney and the State of New South Wales offers:
- Ethics review within 20 days for Phase I and II clinical trials
- 1 ethics application to access the entire state public health system
- Globally competitive costing models
The NSW Government will be releasing a new resource to help optimise your clinical trial experience in NSW.
Please join us at the NSW Government’s BIO 2019 breakfast. REGISTER NOW!.
| Who: | Chair:Rob McInnes, Principal, IP LICENSING & COMMERCIALISATION LAWYER Panel:Anne O’Neill, Director Enterprise and International Partnerships, NSW MINISTRY OF HEALTHDavid Lloyd, Managing Director, SOUTHERN STAR RESEARCHLisa Nelson, CEO, SCIENTIA CLINICAL RESEARCHDavid Barda, Head of Business Development & Innovation, GARVAN INSTITUTE OF MEDICAL RESEARCH |
| Where: | LESCAZE ROOM LOEWS PHILADELPHIA HOTEL 33RD FLOOR, 1200 MARKET STREET PHILADELPHIA |
| When: | Tuesday, 4 June, 20197.00am – 8.45am |
